Menu
Not yet recruiting NCT07580274

Effect of Early vs Late Water Exposure After Cutaneous Surgery

No phase Interventional Surgical Site Infection (SSI)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Care as usual, Care as usual.
Who it may be relevant to
Registry conditions: Surgical Site Infection (SSI). Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effect of Early vs Late Exposure of Water Post-cutaneous Surgeries : A Randomized Controlled Trial

Overview

This randomized controlled trial aims to compare the effect of early versus delayed water exposure after cutaneous surgeries on the incidence of surgical site infections. Patients undergoing elective cutaneous surgical procedures will be randomly assigned to either early postoperative water exposure within 48 hours or delayed exposure after 7 days. Wound outcomes will be assessed using the Southampton Wound Grading System during follow-up visits. The study seeks to determine whether early water exposure is safe and whether it influences postoperative wound healing and infection rates.

Interventions

  • Behavioral Care as usual
    Participants will be allowed early exposure of the postoperative wound to water following cutaneous surgery according to the study protocol.
  • Behavioral Care as usual
    Participants will follow conventional postoperative wound care instructions with delayed exposure of the surgical wound to water.

Primary outcome measures

  • Postoperative Surgical Site Infection [Time frame: 14 days postoperative]

Eligibility criteria

Inclusion criteria

  • Patients undergoing elective surgical procedures, such as excision of benign or malignant skin lesions, skin grafts, and skin biopsies.

Exclusion criteria

  • 1.Patients on anti-coagulants.

2.Compromised immune systems e.g. pregnancy, diabetes, immunosuppressive therapies.

3.Wounds that are located in areas with significant movements (e.g. joints) or that are highly prone to external contaminants (e.g. mucosal surfaces) which might bias result.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07580274 · PEMH-DERM-2026-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗